A series of N-(3-(substituted-alkyl- or halophenyl)-4-methylthiazol-2(3H)-ylidene)-substituted alkyl- or halo-benzamides 21 - 40 were prepared by base-catalyzed cyclization of the corresponding 1-(substituted-alkyl- or halo-benzoyl)-3-(substituted-halophenyl)thioureas 1 - 20. Substituted pyrazolo[ 4,3-d]thiazol-5(6aH)-ylidene)benzamides 45a - d were synthesized by cycloaddition of compound 45 with the reactive cumulene intermediates 42a - d. All compounds were evaluated for their antiviral activity against the replication of HIV-1 and HIV-2 in MT-4. Compounds 35 and 39 showed an IC50 of 2.02 μgmL−1 and 0.40 μgmL−1 against the HIV-2 strain ROD with CC50 of ≥ 104.00 μgmL−1 and > 125.00 μgmL−1, respectively, resulting in a selectivity index of ≥ 52 and > 313. Based on the chemical structure of compounds 35 and 39, these molecules can be proposed to act as NNRTIs. However, it is exceptional to observe an antiretroviral activity that is limited to HIV-2
一系列N-(3-(取代烷基或卤代苯基)-4-甲基噻唑-2(3H)-基)-取代烷基或卤代苯甲酰胺21-40通过对应的1-(取代烷基或卤代苯甲酰)-3-(取代卤代苯基)硫脲1-20的碱催化环化反应制备。通过将化合物45与反应性累烯中间体42a-d进行环加成反应合成了取代吡唑并[4,3-d]噻唑-5(6aH)-基)苯甲酰胺45a-d。评估所有化合物对MT-4中HIV-1和HIV-2的复制的抗病毒活性。化合物35和39对HIV-2 ROD株显示了IC50值分别为2.02 μg/mL和0.40 μg/mL,CC50值分别为≥104.00 μg/mL和>125.00 μg/mL,因此选择性指数分别为≥52和>313。根据化合物35和39的化学结构,这些分子可能作为非核苷逆转录酶抑制剂。然而,观察到限于HIV-2的抗逆转录病毒活性是异常的。